Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1464 | Ordered by Source (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
4P-Pharma. (9/1/16). "Press Release: Signature of a License Agreement with 4P-Pharma for the Development of an Anti-cancer Drug". Talence. 2016-09-01
AAVLife. (4/15/14). "Press Release: AAVLife Raises $12 Million in Series A Financing to Advance Gene Therapy for Friedreich’s Ataxia". Paris. 2014-04-15
AB Science S.A.. (11/14/13). "Press Release: Issue of New Shares". Paris. 2013-11-14
AB Science S.A.. (2/27/15). "Press Release: Quarterly Information – Fourth quarter 2014. Turnover up 10% Compared to 2013 Fourth Quarter". Paris. 2015-02-27
AB Science S.A.. (3/27/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-27
AB Science S.A.. (3/31/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-31
AB Science S.A.. (4/18/16). "Press Release: AB Science Announces the Success of a Private Placement [Not for Distriubution, Publication, Release, Directly or Indirectly, in the United States, Canada, Australia or Japan]". Paris. 2016-04-18
AB Science S.A.. (4/30/15). "Press Release: 2014 Revenues of 2,099 K€. Clinical Trial with Masitinib in 13 Phase 3 Studies". Paris. 2015-04-30
AB Science S.A.. (5/12/17). "Press Release: AB Science Announces that ANSM Requested the Temporary Suspension of Clinical Studies Conducted in France Following Deviations from Good Clinical Practice (GCP) Standards". Paris. 2017-05-12
AB Science S.A.. (7/24/13). "Press Release: AB Science and Its Partners Receive EUR 8.6 Million as Part of a Project Supported by Bpifrance in Alzheimer’s Disease". 2013-07-23
AB Science S.A.. (8/31/15). "Press Release: Turnover of 1,260K€ in the First Half of 2015, Up 23% when Compared with the First Half of 2014". Paris. 2015-08-31
AB Science S.A.. (9/16/15). "Press Release: Masitinib Receives Orphan Drug Designation for Stomach Cancer from FDA". Paris. 2015-09-16
AB Science S.A.. (9/21/15). "Press Release: AB Science Announces Cessation of Its Rheumatoid Arthritis Study in Order to Focus on Clinical Studies with a Probability of Success Greater than 50%". Paris. 2015-09-21
AB Science S.A.. (9/29/16). "Press Release: Filing of Masitinib in the Treatment of Amyotrophic Lateral Sclerosis (ALS) to the European Medicines Agency (EMA)". Paris. 2016-09-29
Abivax S.A.. (1/29/18). "Press Release: Abivax Appoints Carol L. Brosgart, M.D. to Its Board of Directors". Paris. 2018-01-29
Abivax S.A.. (1/9/17). "Press Release: Abivax to Receive €8.4 Million from Bpifrance “Invest in the Future Program” (PIA) for the Development of Innovative Antiviral Drugs". Paris. 2017-01-09
Abivax S.A.. (10/30/14). "Press Release: Abivax Strengthens Executive Management Team with Senior Appointments Karl Birthistle, M.D., Appointed VP of Global Regulatory Affairs Daniel Kenny Appointed Chief Commercial Officer & VP of Business Development". 2014-10-30
Abivax S.A.. (11/12/15). "Press Release: Abivax to Participate in the Upcoming Jefferies Global Healthcare Conference in London and the German Equity Forum in Frankfurt". Paris. 2015-11-12
Abivax S.A.. (11/20/17). "Press Release: Abivax Enrolls First Ulcerative Colitis Patient in New ABX464 Proof-of-Concept Clinical Trial". Paris. 2017-11-20
Abivax S.A.. (12/15/16). "Press Release: Abivax Appoints Didier Blondel as Chief Financial Officer". Paris. 2016-12-15
Abivax S.A.. (12/6/18). "Press Release: Abivax Receives DSMB Recommendation to Continue Ongoing Extension Study of Its Completed Phase 2a Clinical Trial in Ulcerative Colitis patients". Paris. 2018-12-06
Abivax S.A.. (12/7/17). "Press Release: Abivax to Present in Plenary Session at the 8th International Conference on HIV Persistence during Therapy". Paris. 2017-12-07
Abivax S.A.. (2/11/16). "Press Release: Abivax to Participate in the Upcoming RBC Capital Markets 2016 Healthcare Conference in New York, and in the Credit Suisse Healthcare Conference in London". Paris. 2016-02-11
Abivax S.A.. (3/15/16). "Press Release: 2015 Full-Year Results and Progress Report. Significant Progress on Both Cornerstone Programs (HIV and HBV)". Paris. 2016-03-15
Abivax S.A.. (4/9/18). "Press Release: Abivax Strengthens Its Management Team with the Appointment of Alexandra Pearce, Ph.D. as Vice President of Regulatory Affairs". Paris. 2018-04-09
Abivax S.A.. (5/2/17). "Press Release: First Ever Evidence of Treatment-induced Reduction in HIV Reservoirs". Paris. 2017-05-02
Abivax S.A.. (6/12/17). "Press Release: Abivax to Receive €390,000 from Bpifrance for the Development of Its Ebola Hyperimmune Candidate". Paris. 2017-06-12
Abivax S.A.. (6/25/18). "Press Release: Abivax Appoints Ian McGowan as Scientific Advisory Board Chair and Juergen Rockstroh as a New Member". Paris. 2018-06-25
Abivax S.A.. (7/25/18). "Press Release: Abivax Secures up to EUR 20m Debt Financing from Kreos Capital". Paris. 2018-07-25
Abivax S.A.. (9/15/15). "Press Release: Abivax Appoints Antonino Ligresti, MD and Dominique Costantini, MD to its Board of Directors". Paris. 2015-09-15
Abivax S.A.. (9/18/17). "Press Release: First Patient Dosed in Three-month Cohort of Phase 2A Study of Oral ABX464 in HIV-supressed Patients". Paris. 2017-09-18
Abivax S.A.. (9/20/17). "Press Release: Abivax First-half 2017 Financial Results and Update". Paris. 2017-09-20
Abivax S.A.. (9/20/17). "Press Release: Abivax Receives French Regulatory Approval to Begin Clinical Trial of ABX464 in Ulcerative Colitis". Paris. 2017-09-20
Abivax S.A.. (9/28/17). "Press Release: Abivax’s ABX464 Reduces HIV Reservoir in Blood in Second Phase 2a Clinical Trial". Paris. 2017-09-28
Abivax S.A.. (9/4/18). "Press Release: Abivax Reports Impressive Results in Clinical Phase 2a Trial of ABX464 as an Oral Treatment for Ulcerative Colitis Patients". Paris. 2018-09-04
Accovion GmbH. (12/1/14). "Press Release: Accovion Launches New Subsidiary in France". Frankfurt & Eschborn. 2014-12-01
Acticor Biotech. (10/17/18). "Press Release: Acticor Biotech Raises €15.3M in a Series B Financing". Paris. 2018-10-17
Adocia S.A.. (1/18/12). "Press Release: Within the Framework of Its Planned IPO on the Regulated Market of NYSE Euronext in Paris, Adocia Announces the Registration of Its »Document de Base« by the Autorité des Marchés Financiers [Not for US, CA, AU, IT 2012-01-18
Adocia S.A.. (10/11/18). "Press Release: Adocia Informs about a Civil Action Filed by Eli Lilly". Lyon. 2018-10-11
Adocia S.A.. (12/19/14). "Press Release: Lilly and Adocia Announce Alliance to Co-develop Ultra-rapid Insulin Based on BioChaperone Technology". Lyon & Indianapolis, IN. 2014-12-19
Adocia S.A.. (12/9/13). "Press Release: Adocia Signs an Exclusive License on a Nanotechnology which Improves the Efficacy of Anti-tumoral Agents by Targeting Their Action into Tumors". Lyon. 2013-12-09
Adocia S.A.. (2/14/12). "Press Release: Adocia Carris Out, with much Success, the First IPO of the Year on the NYSE Euronext Paris Regulated Market [This document may not be published, distributed or disseminated, directly or indirectly, in the United St 2012-02-14
Adocia S.A.. (2/18/14). "Press Release: Adocia – Annual Revenue of EUR 5.6 M in 2013. The cash position of the Company Amounts to EUR 19.4 M". Lyon. 2014-02-18
Adocia S.A.. (2/27/14). "Press Release: Adocia Announces Preliminary Positive Clinical Results for Its Combination of Long-acting Insulin Glargine and Fast-acting Insulin Analog Lispro, BioChaperone Combo". Lyon. 2014-02-27
Adocia S.A.. (2/6/18). "Press Release: Adocia Files Additional Arbitration Claims Against Eli Lilly & Company". Lyon. 2018-02-06
Adocia S.A.. (3/15/12). "Press Release: Adocia Increase the Size of Its Initial Public Offering to €27.4 Million through the Partial Exercise of the Overallotment Option [Not to Be Published in United States of America, Canada, Australia , Italy or Japan 2012-03-15
Adocia S.A.. (3/19/18). "Press Release: Adocia Announced Its Financial Results for 2017 and Its Perspectives for 2018". Lyon. 2018-03-19
Adocia S.A.. (3/20/14). "Press Release: Adocia Confirms Positive Clinical Results for Its BioChaperone Combo, a Combination of Long-acting Insulin Glargine and Fast-acting Insulin Lispro". Lyon. 2014-03-20
Adocia S.A.. (3/25/14). "Adocia Announces Financial Results for 2013. A Cash Position of EUR 19.4M at End of December 2013". Lyon. 2014-03-25
Adocia S.A.. (4/16/18). "Press Release: Adocia Announces First Quarter 2018 Financial Results: Cash Position and Revenue". Lyon. 2018-04-16
Adocia S.A.. (4/16/18). "Press Release: Adocia Initiates First-in-Human Clinical Study of BioChaperone Pramlintide Insulin in People with Type 1 Diabetes". Lyon. 2018-04-16
Adocia S.A.. (7/18/18). "Press Release: Adocia Presents First Half 2018 Financial Results. Strategic Alliance Signed with Tonghua Dongbao, the Chinese Insulin Leader". Lyon. 2018-07-18
Adocia S.A.. (7/29/13). "Press Release: Adocia Reacquires Exclusive Development Rights to Ultra-fast Acting Insulin Analog. Adocia and Lilly Terminate Collaboration". Lyon. 2013-07-29
Adocia S.A.. (8/20/18). "Press Release: American Arbitration Association Panel Finds In Favor Of Adocia In First Phase Of Arbitration Against Eli Lilly". Lyon. 2018-08-20
Adocia S.A.. (8/30/18). "Press Release: Adocia Announces Update to Second Arbitration Against Eli Lilly & Company". Lyon. 2018-08-30
Adocia S.A.. (9/5/18). "Press Release: Adocia Announces Positive Topline Results for the First Clinical Study of BioChaperone Pramlintide Insulin in People with Type 1 Diabetes". Lyon. 2018-09-05
Adocia S.A.S.. (1/5/10). "Press Release: Adocia Announces Today the Closing of Its Second Financing Round of 14 M€". Lyon. 2010-01-05
Advanced Accelerator Applications S.A.. (10/5/16). "Press Release: Advanced Accelerator Applications S.A. Announces Pricing of $150 Million Public Offering of American Depositary Shares". New York, NY. 2016-10-05
Advanced Chemistry Development, Inc. (ACD/Labs). (1/13/14). "Press Release: Advancing Natural Products Research with ACD/NMR Workbook Suite. Customized and Trainable NMR Prediction Database". Toronto, ON. 2014-01-13
Advanced Chemistry Development, Inc. (ACD/Labs). (12/16/13). "Press Release: The University of Paris Selects ACD/Percepta Software to Enhance Teaching and Research into Pharmaceuticals". Toronto, ON. 2013-12-16
Advanced Chemistry Development, Inc. (ACD/Labs). (12/3/12). "Press Release: Increasing the Efficiency of Complex By-products Research with ACD/Structure Elucidator". Toronto. 2012-12-03
Advanced Chemistry Development, Inc. (ACD/Labs). (3/18/15). "Press Release: Better Academic Chemistry Knowledge Sharing. Building an Analytical Knowledge Management System at the Faculty of Pharmacy of the University of Strasbourg". Strasbourg. 2015-03-18
Advanced Chemistry Development, Inc. (ACD/Labs). (5/17/11). "Press Release: LABERCA, France’s National Reference Laboratory for Food Residues and Contaminants, to Employ ACD/Labs MS Products". Toronto. 2011-05-17
Advent France Biotechnology S.A.S.. (4/20/17). "Press Release: Advent France Biotechnology Announces Its First Life Sciences Dedicated Seed-Fund with a First Closing at €64.75M (USD68.5M)". Paris. 2017-04-20
Advicenne S.A.. (1/24/18). "Press Release: Advicenne Appoints Linda Law, MD as US Vice President, Clinical Development and Medical Affairs". Nîmes. 2018-01-24
Advicenne S.A.. (12/5/17). "Press Release: Advicenne Raises €27 Million in Successful IPO on Euronext Paris [THIS PRESS RELEASE MAY NOT BE PUBLISHED, DISSEMINATED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY TO THE USA, AUSTRALIA, CANADA OR JAPAN]". Nîmes. 2017-12-05
Advicenne S.A.. (3/20/17). "Press Release: Advicenne Announces the Closing of a €16 Million Financing Round". Nîmes. 2017-03-20
Agendia. (12/5/17). "Press Release: Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint BluePrint Breast Cancer Kit Co-Validation Study". Irvine, CA, Amsterdam & Paris. 2017-12-05
Agilent Technologies Inc.. (9/1/10). "Press Release: Maquet SA Adopts Agilent Electronic Lab Notebook Paired with Surety Intellectual Property Integrity Protection". Santa Clara, CA & Reston, VA. 2010-09-01
Alimera Sciences, Inc.. (8/29/17). "Press Release: Alimera Sciences Signs Agreement for Exclusive Distributor of Iluvien in France". Atlanta, GA. 2017-08-29
Alizé Pharma S.A.S.. (12/10/14). "Press Release: Alizé Pharma Announces Positive Results for AZP-531, Its Unacylated Ghrelin Analog, from Two Phase I Clinical Trials in Healthy Volunteers and Obese Subjects". Lyon. 2014-12-10
Alizé Pharma S.A.S.. (12/3/14). "Press Release: Alizé Pharma Acquires Exclusive Worldwide Rights on a New Peptide to Tackle Bone Diseases". Lyon. 2014-12-03
Alizé Pharma S.A.S.. (4/26/16). "Press Release: Alizé Pharma Reports Positive Results from Its Phase II Clinical Trial of AZP-531 in Prader-Willi Syndrome". Lyon. 2016-04-26
Alizé Pharma S.A.S.. (5/11/16). "Press Release: Alizé Pharma II, a Company of the Alizé Pharma Group, Acquired by Jazz Pharmaceuticals". Lyon. 2016-05-11
Alizé Pharma S.A.S.. (9/10/14). "Press Release: Alizé Pharma Raises EUR 5 Million (USD 6.6 Million) from Bpifrance/InnoBio and Its Existing Shareholders". Lyon. 2014-09-10
Alizé Pharma. (1/3/13). "Press Release: Alizé Pharma Launches the PREMAG Research Program". Lyon. 2013-01-03
Alizé Pharma. (2/2/12). "Press Release: Alizé Pharma Licenses Its Asparec Therapy for Treatment of Acute Lymphoblastic Leukemia (ALL) to EUSA Pharma". Lyon. 2012-02-02
Alizé Pharma. (6/4/12). "Press Release: Alizé Pharma Closes 3.3 Million Euro Funding Round". Lyon. 2012-06-04
Alizé Pharma. (9/1/09). "Press Release: Alizé Pharma Closes EUR 3 Million (USD 4.2M) Financing Round". Lyon. 2009-09-01
Alma Bio Therapeutics S.A.S. (6/26/17). "Press Release: Alma Bio Therapeutics and Delphi Genetics Extend Strategic Alliance on Plasmid DNA Drugs". Lyon & Charleroi. 2017-06-26
Amatsigroup. (1/25/16). "Press Release: Amatsigroup Acquires Q-Biologicals and Strengthens Its Offering for International Pharmaceutical Groups". Toulouse. 2016-01-25
Anagenesis Biotechnologies. (12/4/18). "Press Release: Anagenesis Biotechnologies Announces a €3 Million Investment by the Boehringer Ingelheim Venture Fund and Cap Innov’Est". Strasbourg. 2018-12-04
Anagenesis Biotechnologies. (5/18/17). "Press Release: Anagenesis Biotechnologies Announces Strategic Research Agreement with Boehringer Ingelheim to Discover Drugs for Chronic Muscle Diseases". Illkirch Graffenstaden. 2017-05-18
Analytical Pixels Technology S.A.S. (APIX). (2/14/13). "Press Release: APIX Technology Introduces Industry’s First Gas Chromatography Device Based on Silicon Nano-scale Components". Grenoble. 2013-02-14
Analytical Pixels Technology S.A.S. (APIX). (2/7/13). "Press Release: APIX Technology Signs a Comprehensive IP Licensing Agreement with CEA-Leti and Caltech. APIX Secures Rights to Industry Leading Nano-scale Sensor Technology". Grenoble. 2013-02-07
Analytik Jena AG. (3/26/13). "Press Release: Formal Inauguration of Newly Formed Subsidiary in France". Jena & Savigny-le-Temple. 2013-03-26
Andera Partners. (4/4/18). "Press Release: EdRIP becomes Andera Partners. EdRIP Announced the Buyout of the Management Company by Its Employees, in Agreement with Its Majority Shareholder". Paris. 2018-04-04
Angany Genetics. (4/12/13). "Press Release: Angany Genetics Announces the Launch of Its New Production Unit and Gears Up for Supply of Its First Allergens for the Treatment of Dust-mite and Pollens Allergies as from September 2013". Val-de-Reuil. 2013-04-12
Antabio S.A.S.. (7/12/18). "Press Release: Antabio Completes € 12.5m Series A. New Investors Omnes, BNP Paribas Développement and Sham Innovation Santé Invest an Additional €5.2m". Labčge. 2018-07-12
Apix Analytics S.A.. (12/1/17). "Press Release: Apix Analytics Raises 8 Million Euros to Accelerate Its International Development". Grenoble. 2017-12-01
Arbiom Inc.. (12/14/17). "Press Release: Arbiom Led Consortium Receives €4M Refundable Loan from ADEME to Upscale Its Technology Allowing the Production of Sugars and Lignin from Forestry Material". Évry. 2017-12-14
Arbiom Inc.. (7/16/15). "Press Release: OptaFuel and Biométhodes Combine to Form Arbiom". 2015-07-16
Ardian. (9/30/13). "Press Release: Axa Private Equity Becomes Ardian. A New Chapter Begins as an Independent Private Investment Company". Paris. 2013-09-30
Ares Allergy Holdings plc. (9/8/15). "Press Release: Combination of Stallergenes and Greer Laboratories – Creation of the Global Leader in Allergy Immunotherapy [Not for ZA, AU, CA, JP, NZ or US]". London. 2015-09-08
Argos Soditic. (11/18/13). "Press Release: Cisbio Bioassays, in Partnership with Argos Soditic, Makes a Major Step Forward in Its Development". Paris & Codolet. 2013-11-18
AstraZeneca plc. (12/23/09). "Press Release: AstraZeneca to Acquire Infection Research Company Novexel and Expand Collaboration with Forest Laboratories". 2009-12-23
Aureus Sciences S.A.. (5/9/11). "Press Release: Aureus Pharma Changes Name to Aureus Sciences and Launches a New Life Science Applications Portal". 2011-05-09
Balmes Transplantation S.A.S.. (2/6/18). "Press Release: Balmes Transplantation Raises €700,000 in Seed Funding". Marseille. 2018-02-06
Bayer AG. (7/12/12). "Press Release: Kogenate Bayer Was Effective in Reducing Bleeding Frequency when Used as Secondary Prophylaxis in Adults with Severe Hemophilia A [Not intended for U.S. and UK Media]". Berlin. 2012-07-12
Bayer AG. (7/2/12). "Press Release: Bayer to Present Data Hemophilia Research at the WFH 2012 World Congress. SPINART Phase III Clinical Data – BAY 94-9027 Phase I Clinical Trial Data". Berlin. 2012-07-02
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [iito] – Putting Information into Context 600x60px

» top